| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | CFO
3 companies
Hill Matthew C serves as a Chief Financial Officer at APYX and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 9 buys and 0 sells. Those positions are worth an estimated $47K at current prices.
Historically, Hill Matthew C's trades have earned a below-average insider score of 42/100 across 3 rated trades. Over a 12-month horizon, 33.3% of those trades were profitable, with an average 12-month return of +27.6%.
The biggest single holding is PDSB (~$31K) as Chief Financial Officer. Net of sales, the recent Form 4 record there shows accumulation of 3,100 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2024 | APYX Apyx Medical Corp | Chief Financial Officer | Buy | 5,336 | $1.13 | $6,029.68 | +213.4% | +34.5% | +113.6% | |
| Dec 12, 2023 | APYX Apyx Medical Corp | Chief Financial Officer | Buy | 2,500 | $2.19 | $5,475.00 | New | -20.2% | -15.1% | |
| Dec 13, 2021 | PDSB Pds Biotechnology Corp | Chief Financial Officer | Buy | 3,100 | $8.99 | $27,860.00 | +317.9% | -43.9% | -2.1% | |
| Jun 14, 2018 | SSKN Strata Skin Sciences, Inc. | CFO | Buy | 10,000 | $1.96 | $19,618.34 | New | - | - |